Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphorylase kinase regulatory subunit alpha 1 is the alpha subunit of the muscle isoform of phosphorylase kinase, a large multi-subunit enzyme complex essential for glycogen breakdown in skeletal muscle[2][3]. The PHKA1 gene encodes this subunit. Together with the beta and delta (calmodulin) regulatory subunits, alpha 1 modulates the activity of the gamma catalytic subunit in response to hormonal, neural, and calcium signals, thereby regulating energy production. The alpha subunit is phosphorylated by protein kinase A (PKA), enhancing activation in response to cAMP signaling. Mutations in PHKA1 cause glycogen storage disease type IXd, and dysregulation of the complex has also been associated with some tumors[1][2][3].
Allosteric activation of glycogen phosphorylase via regulatory effects on the enzymatic complex Activation by phosphorylation (via PKA) and Ca²⁺/calmodulin binding
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphorylase kinase regulatory subunit alpha 1 (PHKA1).